Diabetes Prevention Program (DPP) for PreDiabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
NYU Langone Health, New York, NY
PreDiabetes+1 More
Diabetes Prevention Program (DPP) - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is studying whether the video-based Diabetes Prevention Program, delivered through the social media platform WeChat, + Community-supported agriculture can prevent diabetes among Chinese immigrants with T2D in NYC. The Diabetes Prevention Program (DPP) will be used to treat patients with PreDiabetes. This is the same program that has previously been approved by the FDA for a different condition. No patients in this trial will receive a placebo.

Eligible Conditions

  • PreDiabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Month 3, Month 6

Month 3, Month 6
Change in International Physical Activity Questionnaire (IPAQ) Short-Version Score
Change in San Francisco Chinese Food Security Module Score
Change in Starting the Conversation (STC) Diet Scale Score
Change in Weight Efficacy Lifestyle Questionnaire (WEL) Score
Percentage Change in Body Weight

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

CONTROL
1 of 2
INCLUDE
1 of 2
Active Control
Experimental Treatment

150 Total Participants · 2 Treatment Groups

Primary Treatment: Diabetes Prevention Program (DPP) · No Placebo Group · N/A

INCLUDEExperimental Group · 2 Interventions: Diabetes Prevention Program (DPP), Community-Supported Agriculture (CSA) · Intervention Types: Behavioral, Behavioral
CONTROLNoIntervention Group · 1 Intervention: CONTROL · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diabetes Prevention Program (DPP)
2012
N/A
~340

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: month 3, month 6
Closest Location: NYU Langone Health · New York, NY
Photo of NYU Langone Health 1Photo of NYU Langone Health 2Photo of NYU Langone Health 3
2020First Recorded Clinical Trial
1 TrialsResearching PreDiabetes
110 CompletedClinical Trials

Who is running the clinical trial?

American Diabetes AssociationOTHER
126 Previous Clinical Trials
97,325 Total Patients Enrolled
NYU Langone HealthLead Sponsor
1,236 Previous Clinical Trials
749,869 Total Patients Enrolled
Lu Hu, PhDPrincipal InvestigatorNYU Langone Medical Center
1 Previous Clinical Trials
60 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing to receive brief videos regarding diabetes prevention, and you have a smartphone or, if you do not have one, you are willing and able to use a study smartphone.
You have a medical diagnosis of prediabetes or have a prediabetes risk test score of greater or equal to 5.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.